Former Wildcat, current NFL player Josh Paschal shares cancer journey in new video

Video produced by the Detroit Lions. To view captions for this video, push play and click on the CC icon in the bottom right-hand corner of the screen. If using a mobile device, click on the “thought bubble” in the same area

LEXINGTON, Ky. (Nov. 5, 2025) — Former University of Kentucky football player Josh Paschal opened up about his melanoma diagnosis and his path to the NFL in a new video released by the Detroit Lions as part of the league’s Crucial Catch initiative.

Paschal, now a defensive end for the Lions, was diagnosed with stage 3B acral lentiginous melanoma in 2018 while playing for UK. He was entering what was expected to be a breakout sophomore season when trainers noticed an unusual spot on the bottom of his foot during a routine ankle taping.

The melanoma had spread to lymph nodes in his groin, requiring two surgeries to remove the tumor and reconstruct tissue in his foot. B. Mark Evers, M.D., director of the UK Markey Cancer Center, performed Paschal's surgeries and worked with a team of other specialists to develop a treatment plan. He underwent a year of immunotherapy treatment, which helped his immune system attack the cancer cells, while learning to walk and play football again.

Paschal returned to the field later that 2018 season and went on to become one of the SEC’s top defensive players during his senior year before being drafted by the Detroit Lions in 2022.

He now uses his public profile to raise awareness about melanoma, particularly among young people and Black men, who often face delayed diagnosis and worse outcomes.

“If it just touches one person and they notice something in their body and they get it checked out, that’s saving a life,” Paschal said.

The full video is available on the Detroit Lions YouTube channel.

of
Josh Paschal on the field in UK uniform.
Peng Wang and Josh Paschal
Josh Paschal lifting weights in the gym
Action shot of Josh Paschal on the football field.

UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is more than 10,000 dedicated health care professionals committed to providing advanced subspecialty care for the most critically injured and ill patients from the Commonwealth and beyond. It also is the home of the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, a Level IV Neonatal Intensive Care Unit that cares for the tiniest and sickest newborns and the region’s only Level 1 trauma center.

As an academic research institution, we are continuously pursuing the next generation of cures, treatments, protocols and policies. Our discoveries have the potential to change what’s medically possible within our lifetimes. Our educators and thought leaders are transforming the health care landscape as our six health professions colleges teach the next generation of doctors, nurses, pharmacists and other health care professionals, spreading the highest standards of care. UK HealthCare is the power of advanced medicine committed to creating a healthier Kentucky, now and for generations to come.